Tvardi Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$3.29

-0.07 (-2.08%)

As of Mar 25, 10:10 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 9 64%

Hold 5 36%

Sell 0 0%

Price Target

Analyst Price Target +1,057.1% upside

Low Target $23.38

Average Target $38.07

High Target $43.34

Current Price $3.29

Current
$3.29

Target
$38.07

$23.38 $38.07 avg $43.34

Scenario Analysis

Bear Case

$23.38

610.6%

Low target

Base Case

$38.07

+1,057.1%

Avg target

Bull Case

$43.34

+1,217.3%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$43.65

-92.5% from high

52-Week Low

$3.38

+-2.7% from low

Target vs 52W High

$38.07

-12.8% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%